[PDF][PDF] A viro-immunotherapy triple play for the treatment of glioblastoma
JC Bell, CS Ilkow - Cancer Cell, 2017 - cell.com
JC Bell, CS Ilkow
Cancer Cell, 2017•cell.comIn this issue of Cancer Cell, Saha et al. systematically test and optimize combination therapy
strategies in a challenging model of glioblastoma. Durable complete responses were seen
only when an oncolytic virus expressing IL12 was coupled with anti-CTLA-4 and anti-PD-1
therapeutics.
strategies in a challenging model of glioblastoma. Durable complete responses were seen
only when an oncolytic virus expressing IL12 was coupled with anti-CTLA-4 and anti-PD-1
therapeutics.
In this issue of Cancer Cell, Saha et al. systematically test and optimize combination therapy strategies in a challenging model of glioblastoma. Durable complete responses were seen only when an oncolytic virus expressing IL12 was coupled with anti-CTLA-4 and anti-PD-1 therapeutics.
cell.com